| A2AR | A2A-receptor |
| ADO | Extracellular adenosine |
| CA-IX | Carbonic anhydrase IX |
| CCR | CC chemokine receptors |
| CNS | Central nervous system |
| CTL | Cytotoxic T-lymphocyte |
| CTLA-4 | Cytotoxic-T-lymphocyte protein 4 |
| DAPI | 4′,6-diamidino-2-phenylindole |
| GLUT | Glucose transporter |
| H&E | Hematoxylin and eosin |
| HIF | Hypoxia-inducible factor |
| HRP | Horseradish peroxidase |
| ICD | Immunogenic cell death |
| ICI | Immune checkpoint inhibitor |
| IF | Immunofluorescence |
| IHC | Immunohistochemistry |
| IL | Interleukin |
| IPI | Ipilimumab |
| LAG3 | Lymphocyte-activation gene 3 |
| LN | Lymph node |
| mAb | Monoclonal antibody |
| MBM | Melanoma brain metastases |
| OS | Overall survival |
| PD-1 | Programmed cell death protein 1 |
| ROI | Region of interest |
| RT | Radiotherapy |
| STX | Stereotactic brain radiotherapy |
| TIL | Tumor-infiltrating lymphocytes |
| TME | Tumor microenvironment |
| WBRT | Whole-brain radiotherapy |